What are the opening hours?

Monday 9am - 6pm Tuesday 9am - 6pm Wednesday 9am - 6pm Thursday 9am - 6pm Friday 9am - 6pm

MedGenome

Home
India
Bangalore
MedGenome

MedGenome is a leading provider of molecular diagnostics solutions to hospitals and clinicians.

MedGenome is a leading provider of molecular diagnostics solutions to hospitals and clinicians, enabling personalized healthcare. Its innovative offerings in molecular diagnostics apply advanced software and bioinformatics tools to curated omics data, combined with MedGenome’s proprietary knowledge base and powerful analytics. MedGenome’s genomics bioinformatics platform is available to global pharmaceuticals, research and diagnostics organizations. MedGenome has pioneered Whole Genome, Whole Exome and Multi-Gene Panel disease panel based diagnostics in India. MedGenome genomic products and services will empower doctors and patients in matters of health and disease management by providing them with relevant genetic information. MedGenome has developed many single gene tests, disease panels and investigational tests covering Oncology, Pediatrics, Prenatal, Cardiology, Ophthalmology, Neurology, and other specialties. Our OncoMD Cancer Analytics Platform curates and validates genomics and proteomics data captured from leading peer reviewed scientific journals and other relevant data sources. The platform combines curated data with software bioinformatics and powerful analytics to deliver actionable information for clinical diagnosis and treatment decisions. MedGenome also partners with clients on genomic based exploratory research and drug discovery. Our ability to leverage existing longitudinal studies, design population studies from scratch and also conduct follow up studies on cohorts provides valuable benefits to our global research partners

MedGenome was incubated for 2 years as a division of SciGenom Labs, Cochin, India. It was spun off as a separate company with headquarters in Narayana Health City, Bangalore in 2013. MedGenome at Narayana Nethralaya (NN) has a co-located lab spanning over 10,000 sq.ft of lab space at Narayana Nethralaya. MedGenome has a multi faceted team spread across the country, facilitating its pan India operations.

15/12/2025

Learn how genome-wide methylation profiling is transforming CNS tumour diagnosis, read our blog:
https://diagnostics.medgenome.com/medgenomes-cns-tumour-methylation-classifier-a-breakthrough-in-brain-tumour-diagnostics/

Diagnosing CNS tumors accurately remains one of the biggest challenges in neuro-oncology. MedGenome’s CNS Tumour Methylation Classification Test, India’s first genome-wide methylation-based diagnostic for CNS tumors, helps close the diagnostic gap by delivering a precise molecular fingerprint of the tumor. By refining, confirming, or even redefining the diagnosis, this test empowers clinicians with clarity that guides targeted treatment decisions, improves subtype accuracy, reduces overtreatment, and supports better patient outcomes.

To know more, reach out to us,
📞1800 296 9696 | 📩 diagnostics@medgenome.com

14/12/2025

At MedGenome, the drive to collaborate, innovate, and excel isn't just part of what we do – it's in our genes.

Our annual event, Triple Panga, transformed our office into a lively environment full of creativity, strategic thinking, and bonding. With an enthusiastic turnout, the participants showcased both sharp thinking and perseverance in every game. Through each move, strike, and guess, we strengthened bonds, boosted confidence, and created lasting memories.

12/12/2025

MedGenome was proud to participate in the 10th Annual Conference of the Society for Indian Academy of Medical Genetics (IAMG 2025) in Pune, held from 5th–7th December 2025.

At the event, MedGenome introduced ExomeMAX Reflex Whole Genome Sequencing, presented several scientific posters, and attended an insightful session by Dr. Ramprasad, CEO, MedGenome Labs, on genetic risk stratification in common diseases. We also hosted an engaging genetics quiz, which received enthusiastic participation from attendees.

10/12/2025

In AML, NPM1 mutations influence disease progression and therapeutic strategies.

Even after remission, residual disease cells can persist and lead to relapse. NPM1-MRD Detect assay helps identify early traces of leukemia, and guides timely targeted therapy.

In AML, every cell matters—and every outcome deserves precision. To know more, reach out to us,
📞1800 296 9696 | 📩 diagnostics@medgenome.com

04/12/2025

Explore MedGenome’s world-class genomics lab today!🧪
Visit medgenome.com or call 1800 296 9696 to know more.

Take a peek into MedGenome, South Asia's largest CAP and NABL-accredited multi-omics laboratory. With cutting-edge technologies, AI/ML-enabled tools, and the expertise of our brilliant scientists, we’re pushing the boundaries of healthcare to make genomics accessible for all.

02/12/2025

Featured in for Lung Cancer Awareness Month.

Read here: https://www.timesnownews.com/health/how-genetics-is-changing-everything-we-know-about-lung-cancer-article-153219412

Genetics has now been identified to play a major role in lung cancers, whether triggered by lifestyle and environmental factors or inherited mutations. . Prashanth Bagali explains that understanding the genetic makeup of a tumour is crucial to identifying the exact mutations that influence how the disease develops and how well a patient may respond to treatment. This level of insight is transforming lung cancer care, enabling more precise, targeted therapies and offering patients better outcomes and improved survival rates.

01/12/2025

Join us for an engaging webinar on Lung Cancer Genetics, exploring how next-generation sequencing (NGS) is reshaping lung cancer diagnosis and management, from early detection to treatment decisions, featuring:
Dr. Boman Dhabhar, Director Oncology, Fortis Hospital, Mumbai
Dr. Bharat Bhosale, Sr Consultant Oncologist, Bombay Hospital, Mumbai
Dr. Syed Muqlisur Rehman, Associate Director – Molecular Path, MedGenome Labs, Bangalore
Date: 6th December 2025
Time: 5 PM – 6 PM
Register now to learn how comprehensive genomic profiling and NGS-guided insights are reshaping personalised care and tackling treatment resistance in lung cancer: https://tinyurl.com/2tvphywy

27/11/2025

Dr. Priya Kadam, Director of Reproductive Genomics at MedGenome Labs, discusses the clinical benefits of the KaryoSeq HD test. This high-resolution, low-pass whole genome sequencing test is designed to detect aneuploidies and copy number variations (CNVs) of 50 kilobases or greater, providing valuable insights into chromosomal abnormalities. Learn more about how KaryoSeq HD can enhance your diagnostic approach.

For more information, call us at 1800 296 9696 or email diagnostics@medgenome.com.

26/11/2025

Our month-long Kannada Rajyotsava celebrations at MedGenome honoured Karnataka’s rich heritage through themes like Operation Diamond Racket, celebrating the growth of Kannada cinema, and Kannadada Kantara, highlighting divinity, mysticism and our deep bond with nature. The festivities came alive with employees in vibrant red and yellow, floors adorned in festive décor and a spread of Karnataka-inspired snacks that filled our workspace with local flavours.

Here’s to celebrating culture, community and togetherness. Happy Kannada Rajyotsava!

24/11/2025

Take the poll and tell us what you think!

22/11/2025

Think you know what hints at monogenic (MODY) diabetes?

Take the poll and share your pick.

21/11/2025

We are pleased to share that Dr. Priya Kadam, Director of Reproductive Genomics, MedGenome, represented the company at THE WEEK Health Summit 2025.

Dr. Kadam delivered an insightful session on “The Genetics of Healthier Futures”, sharing deep insights on reproductive genomics, the importance of early genetic testing, and the impact of Non-Invasive Prenatal Testing (NIPT) in ensuring informed decisions for every pregnancy, emphasizing the need for integrating genomics into routine healthcare.

As genomics is reshaping reproductive health, MedGenome continues to pioneer this transformation by enabling informed, healthier futures for families.

Address

MedGenome Labs Ltd. Sy. Nos. 94/1C And 94/2, Tower 1, Ground Floor, Veerasandra Village, Attibele Hobli, Electronic City Phase-1, Electronics City
Bangalore
560100

Opening Hours

Monday	9am - 6pm
Tuesday	9am - 6pm
Wednesday	9am - 6pm
Thursday	9am - 6pm
Friday	9am - 6pm

Telephone

+9118001033691

Website

http://www.medgenome.com/

Alerts

Be the first to know and let us send you an email when MedGenome posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to MedGenome:

Shortcuts

Address
Telephone
Opening Hours
Alerts
Contact The Practice
Claim ownership or report listing

Want your practice to be the top-listed Clinic in Bangalore?